Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 1995
The accuracy of CT-based inhomogeneity corrections and in vivo dosimetry for the treatment of lung cancerM Essers, J H Lanson, G Leunens, et al.International Journal of Radiation Oncology, Biology, Physics|December 1, 1995
Dosimetric characteristics of a liquid-filled electronic portal imaging deviceM Essers, B R Hoogervorst, M van Herk, et al.Xenotransplantation|February 24, 2001
Both IgG and IgM anti-pig antibodies induce complement activation and cytotoxicityA Roos, M Essers, D van Gijlswijk-Janssen, et al.The Analyst|August 1, 1996
Development of a tube enzyme immunoassay for "on-site' screening of urine samples in the presence of beta-agonistsW Haasnoot, L Streppel, G Cazemier, et al.International Journal of Radiation Oncology, Biology, Physics|April 13, 2000
Beam intensity modulation for penumbra enhancement in the treatment of lung cancerM L Dirkx, M Essers, J R van Sornsen de Koste, et al.BJU International|April 3, 2009
Ubiquitin hydrolase (protein gene product 9.5) in the obstructed bladder: evidence for tissue remodelling involving a subset of interstitial cellsSimone Grol, Paul B M Essers, Gommert A van Koeveringe, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 30, 1999
In vivo dosimetry during conformal radiotherapy: requirements for and findings of a routine procedureJ H Lanson, M Essers, G J Meijer, et al.Nederlands Tijdschrift Voor Geneeskunde|June 30, 2017
['Ecstasy-light' - not as light as its name suggests: toxic effects of 4-fluoroamphetamine]M C J Knippels, I M M Essers, F J H Magdelijns, et al.Research in Developmental Disabilities|December 3, 2014
Efficacy of upper limb strengthening in children with Cerebral Palsy: A critical reviewE A A Rameckers, Y J M Janssen-Potten, I M M Essers, et al.British Journal of Cancer|March 10, 1999
Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG)A Kuin, M Aalders, M Lamfers, et al.Pageof 4